FDA Re-evaluating Drug Data Generated By Fraudulent Clinical Investigator
Executive Summary
FDA is reviewing data related to drug studies conducted by clinical investigator Robert Fiddes, MD, to ensure the safety and effectiveness of products for which he falsified clinical trial data.
You may also be interested in...
FDA's Data Falsification Proposed Rule Is Overly Strict, Sponsors Say
Agency needs to better define the evidence threshold for reporting suspected clinical trial fraud to the agency, industry commenters say.
Manufacturers Should Oversee CROs, Investigators – U.S. Prosecutor Sheehan
Pharmaceutical manufacturers will be held liable for the conduct of contract research organizations and principal investigators, Assistant U.S. Attorney Jim Sheehan said
Manufacturers Should Oversee CROs, Investigators – U.S. Prosecutor Sheehan
Pharmaceutical manufacturers will be held liable for the conduct of contract research organizations and principal investigators, Assistant U.S. Attorney Jim Sheehan said